MOLOGEN uses DNA as a medicine for illnesses that are currently not or only insuf-ficiently treatable. The core of the development work is formed by the MIDGE and dSLIM technologies patented by MOLOGEN. Vaccinations and therapies for the prophylactic and therapeutic treatment of a broad spectrum of serious illnesses are developed by MOLOGEN on this basis. At present, MOLOGEN is approaching pharmaceutical companies in order to enter into collaborations with them and to mature these medicines for the market.
